Feasibility study of a human papillomavirus E6 oncoprotein test for diagnosis of cervical precancer and cancer

Journal of Clinical Microbiology

Volumn 48, Issue 12, 2010, Pages 4646-4648

  Schweizer, Johannes ^a   Lu, Peter S ^a   Mahoney, Charles W ^a   Berard Bergery, Marthe ^a   Ho, Minh ^a   Ramasamy, Valli ^a   Silver, Jon E ^a   Bisht, Arnima ^a   Labiad, Yassine ^a   Peck, Roger B ^b   Lim, Jeanette ^b   Jeronimo, Jose ^b   Howard, Roslyn ^c   Gravitt, Patti E ^c   Castle, Philip E ^d  

^a Arbor Vita Corporation   (United States)

^b Program for Appropriate Technology in Health   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN E6;

ARTICLE; FEASIBILITY STUDY; FEMALE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 45; NONHUMAN; PRIORITY JOURNAL; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU;

FEASIBILITY STUDIES; FEMALE; HUMANS; IMMUNOASSAY; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS; VIROLOGY;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16;

EID: 78650061716     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.01315-10     Document Type: Article

References (10)

1. Bouvard, V., R. Baan, K. Straif, Y. Grosse, B. Secretan, F. El Ghissassi, L. Benbrahim-Tallaa, N. Guha, C. Freeman, L. Galichet, and V. Cogliano on behalf of the WHO International Agency for Research on Cancer Monograph Working Group. 2009. A review of human carcinogens-Part B: biological agents. Lancet Oncol. 10:321-322.
2. Castle, P. E., P. E. Gravitt, D. Solomon, C. M. Wheeler, and M. Schiffman. 2008. Comparison of linear array and line blot assay for detection of human papillomavirus and diagnosis of cervical precancer and cancer in the atypical squamous cell of undetermined significance and low-grade squamous intraepithelial lesion triage study. J. Clin. Microbiol. 46:109-117.
3. Cuzick, J., C. Clavel, K. U. Petry, C. J. Meijer, H. Hoyer, S. Ratnam, A. Szarewski, P. Birembaut, S. Kulasingam, P. Sasieni, and T. Iftner. 2006. Overview of the European and North American studies on HPV testing in primary cervical cancer screening. Int. J. Cancer 119:1095-1101. (Pubitemid 44116919)
4. McCredie, M. R., K. J. Sharples, C. Paul, J. Baranyai, G. Medley, R. W. Jones, and D. C. Skegg. 2008. Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study. Lancet Oncol. 9:425-434.
5. Parkin, D. M. 2006. The global health burden of infection-associated cancers in the year 2002. Int. J. Cancer 118:3030-3044.
6. Qiao, Y. L., J. W. Sellors, P. S. Eder, Y. P. Bao, J. M. Lim, F. H. Zhao, B. Weigl, W. H. Zhang, R. B. Peck, L. Li, F. Chen, Q. J. Pan, and A. T. Lorincz. 2008. A new HPV-DNA test for cervical-cancer screening in developing regions: a cross-sectional study of clinical accuracy in rural China. Lancet Oncol. 9:929-936.
7. Sankaranarayanan, R., B. M. Nene, S. S. Shastri, K. Jayant, R. Muwonge, A. M. Budukh, S. Hingmire, S. G. Malvi, R. Thorat, A. Kothari, R. Chinoy, R. Kelkar, S. Kane, S. Desai, V. R. Keskar, R. Rajeshwarkar, N. Panse, and K. A. Dinshaw. 2009. HPV screening for cervical cancer in rural India. N. Engl. J. Med. 360:1385-1394.
8. Schiffman, M., and A. C. Rodriguez. 2008. Heterogeneity in CIN3 diagnosis. Lancet Oncol. 9:404-406.
9. Smith, J. S., L. Lindsay, B. Hoots, J. Keys, S. Franceschi, R. Winer, and G. M. Clifford. 2007. Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. Int. J. Cancer 121:621-632.
10. Stoler, M. H., and M. Schiffman. 2001. Interobserver reproducibility of cervical cytologic and histologic interpretations: realistic estimates from the ASCUS-LSIL Triage Study. JAMA 285:1500-1505.